Technology: Pharmaceuticals
Industry: Regenerative medicine
Headquarters: United States
Investors Number: 11
Total Funding: $700M
Estimated Revenue: $1M to $10M
Last Funding Type: Series A

Visit Website
bd@stemcentrx.com
twitter.com/stemcentrx
Register and Claim Ownership